August 2015

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Swati R. Dhande, Aruhana R. Patil*, Lilasrao J. Kadam
Bharati Vidyapeeth's College of Pharmacy,
Belapur, Navi Mumbai
*arpatil1991@gmail.com

ABSTRACT
Diabetes Mellitus (DM) is a metabolic endocrine disorder. It is one of the most rapidly growing diseases worldwide. Various pharmacotherapies have been practiced in the cure and management of DM. The existing conventional therapies aims at reducing hyperglycemia and achieving better glycemic control over the time, but fail to combat the other risk factors associated with the disease. The newer approaches are targeting to combat the risk factors and reduce the progression of disease. The newer approaches includes regenerational therapies, use of herbal and natural supplements, use of antioxidants and use combinations of conventional therapies with above mentioned therapies. Though these combinations have been found to be promising in the management of DM, the risk of pharmacological interactions cannot be overlooked. The present study was conducted to evaluate the pharmacokinetic interaction between DPP-IV inhibitor sitagliptin and a nutraceutical Z. officinale. STZ (Streptozotocin) and HFD (High Fat Diet) induced Type II DM rat model was used and the possible interaction was determined. The evaluation was done on validated HPTLC bioanalytical method. The present combination of sitagliptin and ginger did not affect the pharmacokinetic profile of sitagliptin.

Sai CRI is a Chennai based Indian organization, provider of International Clinical Research Education and Job Placement Support for medical or life science professionals, interested to enter the rewarding field of clinical trial administration and management.
It was established to provide affordable CRP (Clinical Research Professional) certification training, combined with practical internship and job insertion and placement assistance, a very needed active service, not offered by other providers, and to create jobs and job opportunities for its members.

Post: Clinical Research Associate

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics — ensuring a higher level of healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.
Quintiles is consistently cited as the most favored contract research organization (CRO) in independent surveys of the bio pharma industry and was recently named “2009 CRO of the Year” by the prestigious SCRIP Awards.

Post: Operations Specialist-1514699

Increased life expectancy coupled with ever-growing rate of literacy and higher income level, have raised the higher demand for quality treatment warranting a sound support system for the health care system. With advancement in medical sciences and concomitant growing demand for qualified and trained personnel in Pharmacy, need for well-qualified industry-ready bright Pharmacy graduates is being felt like never before, more so in West Bengal.
To meet the situation, the entrepreneurs associated with Dr. B. C. Roy Group of Colleges, with support from like-minded professionals founded Dr. B. C. Roy College of Pharmacy and Allied Health Sciences in September, 2005 at the centre of Durgapur Steel City on aroun four acres of Govt. land procured from ADDA, Govt. of West Bengal.

Post: Professors & Associate Professor

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Clinical Data Analyst